VIRMA and gastric adenocarcinoma: The analysis revealed that VIRMA expression was higher in HNSC, lung squamous cell carcinoma (LUSC), liver hepatocellular carcinoma (LIHC), colon adenocarcinoma (COAD), rectum adenocarcinoma (READ), lung adenocarcinoma (LUAD), stomach adenocarcinoma (STAD), cholangiocarcinoma (CHOL), breast invasive carcinoma (BRCA), kidney chromophobe (KICH) and kidney renal clear cell carcinoma (KIRC).